Gallicano, G.I.; Fu, J.; Mahapatra, S.; Sharma, M.V.R.; Dillon, C.; Deng, C.; Zahid, M.
Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy. Pharmaceuticals 2022, 15, 871.
https://doi.org/10.3390/ph15070871
AMA Style
Gallicano GI, Fu J, Mahapatra S, Sharma MVR, Dillon C, Deng C, Zahid M.
Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy. Pharmaceuticals. 2022; 15(7):871.
https://doi.org/10.3390/ph15070871
Chicago/Turabian Style
Gallicano, G. Ian, Jiayu Fu, Samiksha Mahapatra, Michael V. R. Sharma, Conor Dillon, Claire Deng, and Maliha Zahid.
2022. "Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy" Pharmaceuticals 15, no. 7: 871.
https://doi.org/10.3390/ph15070871
APA Style
Gallicano, G. I., Fu, J., Mahapatra, S., Sharma, M. V. R., Dillon, C., Deng, C., & Zahid, M.
(2022). Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy. Pharmaceuticals, 15(7), 871.
https://doi.org/10.3390/ph15070871